Primary antifungal prophylaxis in hematological malignancies. Updated clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL) - Pagano, Livio; Maschmeyer, Georg; Lamoth, Frederic; Blennow, Ola; Xhaard, Alienor; Spadea, Manuela; Busca, Alessandro; Cordonnier, Catherine; Maertens, Johan (Leukemia, 2025)
Keywords: 692/308/174; 692/699/255/1672; Acute myeloid leukemia; Antifungal Agents - therapeutic use; Aspergillosis; Azacytidine; Bispecific antibodies; Cancer Research; Caspofungin; Chemotherapy; Chronic lymphocytic leukemia; Clinical medicine; Critical Care Medicine; Disease prevention; Drug interactions; Epidemiology; Evidence-based medicine; Fungal diseases; Fungicides; Guidelines; Health services; Hematologic Neoplasms - complications; Hematologic Neoplasms - therapy; Hematology; Hematopoietic stem cells; Hodgkin's lymphoma; Humans; Induction therapy; Infections; Intensive; Internal Medicine; Leukemia; Life Sciences; Lymphocytes; Lymphocytes T; Lymphoma; Malignancy; Medicine; Medicine & Public Health; Micafungin; Mold; Multiple myeloma; Mycoses - etiology; Mycoses - prevention & control; Myelodysplastic syndrome; Neoplasms; Oncology; Patients; Pediatrics; Posaconazole; Practice Guidelines as Topic; Prophylaxis; Remission; Remission (Medicine); Review; Review Article; Risk; Stem cell transplantation; Stem cells; Working groups